Our brains make countless decisions every day, from choosing whether to cross the road to selecting the most efficient route to the supermarket. Yet many of these decisions, even those that require our brains to factor in ...
Dec 16, 2021
0
3
An international team has developed statistical models to predict the risk of early death in patients being treated with non-intensive therapies for acute myeloid leukemia (AML). Results of analyses using the models will ...
Dec 12, 2021
0
1
Local COVID-19 transmission was underway in California, New York, Florida and Texas well before the first reported U.S. case in Washington state on Jan. 20, 2020, according to a new study published in Nature, which indicates ...
Dec 8, 2021
0
73
The amount of a SARS-CoV-2 genetic material—viral RNA—in the blood is a reliable indicator in detecting which patients will die of the disease, a team led by Université de Montréal medical professor Dr. Daniel Kaufmann ...
Nov 26, 2021
0
210
Zinc deficiency is prevalent around the world, and among children, these mineral shortfalls can lead to stunting, embryonic malformations and neurobehavioral abnormalities. Over several decades, science has improved understanding ...
Nov 17, 2021
0
0
Combining electroencephalogram (EEG) data with clinical observations can help doctors to better determine whether generalized epilepsy patients will respond to treatment, according to a study led by Rutgers researchers.
Oct 28, 2021
0
3
Mathematical modeling of disease spread suggests that herd immunity could be achieved with fewer vaccine doses by using Bluetooth-based contact-tracing apps to identify people who have more exposure to others—and targeting ...
Sep 22, 2021
0
108
A suicide screening tool developed by researchers from Duke Health and the Department of Veterans Affairs is far more accurate at identifying patients at risk for attempting suicide than current clinical assessments, which ...
Sep 15, 2021
0
10
Immunotherapy agents that inhibit the molecules PD1, PD-L1 or CTLA-4 have become widely used in clinical practice to treat non-small cell lung cancer, or NSCLC. Approximately 20% to 50% of advanced NSCLC patients have strong ...
Aug 20, 2021
0
47
One of the major challenges in modern cancer therapy is the adaptive response of cancer cells to targeted therapies: initially, these therapies are very often effective, then adaptive resistance occurs, allowing the tumor ...
Jul 21, 2021
0
4
